OR WAIT null SECS
May 18, 2023
Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.
May 17, 2023
The new method was developed to isolate tissue-specific EVs from the blood in addition to using a workflow to analyze their diverse multi-omics content.
This deal would help the companies merge to work on future projects and conduct research together.
May 16, 2023
Synthego has opened its new GMP-compliant RNA manufacturing facility in Redwood City, Calif., for CRISPR-enabled genomics therapeutics.
The Agilent 8697 Headspace Sampler-XL Tray has a 120-vial capacity.
The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.
May 15, 2023
Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.
May 12, 2023
This approach is defined as being used to express transcription factor combinations to reprogram human induced pluripotent stem cells (iPSCs).
May 11, 2023
The objective of the partnership is to automate portions of ScaleReady’s CGT manufacturing workflow by using Cellular Origin’s robotic system for sterile liquid transfer.
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).